Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank-Reference-Cited by-同舟云学术

Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank

Published:2021-11-08 Issue: Volume: Page:
ISSN:0307-0565
Container-title:International Journal of Obesity
language:en
Short-container-title:Int J Obes

Author:

De Vincentis Antonio,Tavaglione Federica,Spagnuolo Rocco,Pujia Roberta,Tuccinardi Dario,Mascianà Gianluca,Picardi Antonio^ORCID,Antonelli Incalzi Raffaele,Valenti Luca,Romeo Stefano^ORCID,Vespasiani-Gentilucci Umberto^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Nutrition and Dietetics,Endocrinology, Diabetes and Metabolism,Medicine (miscellaneous)

Link

https://www.nature.com/articles/s41366-021-01015-w.pdf

Reference39 articles.

1. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11–20.

2. European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. J Hepatol. 2016;64:1388–402.

3. Bellentani S, Saccoccio G, Masutti F, Crocè LS, Brandi G, Sasso F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med. 2000;132:112–7.

4. Berg EHvanden, Amini M, Schreuder TCMA, Dullaart RPF, Faber KN, Alizadeh, et al. Prevalence and determinants of non-alcoholic fatty liver disease in lifelines: a large Dutch population cohort. PLOS ONE. 2017;12:e0171502.

5. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–31.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modifiable lifestyle factors, genetic and acquired risk, and the risk of severe liver disease in the UK Biobank cohort;Digestive and Liver Disease;2024-01

2. High-density lipoproteins and non-alcoholic fatty liver disease;Atherosclerosis Plus;2023-09

3. Lower creatinine to cystatin C ratio is associated with an increased risk of MAFLD: A cross-sectional and prospective study of 368,634 UK Biobank participants;2023-07-21

4. Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease;Journal of Hepatology;2023-01

5. Biobanking as a Tool for Genomic Research: From Allele Frequencies to Cross-Ancestry Association Studies;Journal of Personalized Medicine;2022-12-09